BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2014 12:00:00 PM | Browse: 375 | Download: 435
Publication Name World Journal of Diabetes
Manuscript ID 4959
Country of Manuscript Source Brazil
Received
2013-08-14 08:43
Peer-Review Started
2013-08-15 10:19
To Make the First Decision
2013-08-21 18:44
Return for Revision
2013-08-29 17:31
Revised
2013-10-21 02:33
Second Decision
2014-01-16 14:25
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-16 14:41
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-02-15 16:55
Publish the Manuscript Online
2014-02-19 15:19
ISSN 1948-9358 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Endocrinology and Metabolism
Manuscript Type Autobiography
Article Title Starting glargine in insulin-naïve type 2 diabetic patients based on body mass index is safe
Manuscript Source Invited Manuscript
All Author List Denise R Franco, Juliana Baptista, Fatima RM Abreu, Risoneide B Batista and Freddy G Eliaschewitz
Funding Agency and Grant Number
Funding Agency Grant Number
Sanofi-Aventis Brazil
Corresponding author Denise R Franco, MD, Medical Department, Clinical Research Center (CPCLIN), Rua Goias 193, São Paulo 01244-030, Brazil. d9franco@terra.com.br
Keywords Type 2 diabetes; Insulin glargine; Basal insulin; Hypoglycemia; Titration algorithms
Core Tip To start insulin therapy in insulin na?ve type 2 diabetes patients, a long-acting basal insulin, such as insulin glargine, is added once a day. The majority of algorithms determine insulin titration according to fasting plasma glucose levels, but the dosage differs at the initial dose, frequency and speed of adjustments. It is difficult to compare the different algorithms employed in trials with populations of different socio-economic strata and variable access to educational materials. Here, we compared the safety of different titration algorithms in a population that was homogeneous in terms of socio-economic strata and with the same degree of education in diabetes.
Publish Date 2014-02-19 15:19
Citation Franco DR, Baptista J, Abreu FRM, Batista RB, Eliaschewitz FG. Starting glargine in insulin-na?ve type 2 diabetic patients based on body mass index is safe. World J Diabetes 2014; 5(1): 69-75 Available from: URL: http://www.wjgnet.com/1948-9358/ full/v5/i1/69.htm DOI: http://dx.doi.org/10.4239/wjd.v5.i1.69
Url http://www.wjgnet.com/1948-9358/full/v5/i1/69.htm
DOI http://dx.doi.org/10.4239/wjd.v5.i1.69
Full Article (PDF) WJD-5-69.pdf
Full Article (Word) WJD-5-69.doc
Manuscript File 4959-Review.doc
Answering Reviewers 4959-Answering reviewers.pdf
Copyright License Agreement 4959-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 4959-Language certificate.pdf
Peer-review Report 4959-Peer reviews.pdf
Scientific Editor Work List 4959-Scientific editor work list.doc